A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug

NCT00382668 · clinicaltrials.gov ↗

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Diseases

Interventions

DRUG: Dasatinib
DRUG: Dasatinib
DRUG: Dasatinib

Sponsor

Bristol-Myers Squibb